Skip to main content
. 2017 Sep 15;3:13. doi: 10.1038/s41514-017-0013-z

Table 1.

Hormesis conceptual refinements since the year 2000

No.
1 Hormesis as a measure of biological performance for integrative endpoints.
2 Biological performance that is enhanced via hormesis is constrained by the limits of plasticity.
3 Hormesis is highly generalizable.
4 Hormesis is frequent in the biological/biomedical literature.
5 Hormetic mechanisms are now extensively documented.
6 Quantitative features of hormetic dose responses are independent of hormetic mechanisms.
7 Pre-, post-, and remote-conditioning are manifestations of hormesis.
8 Hormesis has a key role in drug development.
9 Hormesis is similar in normal and high-risk groups.
10 Integration of LNT and hormesis may optimize cancer risk assessment.
11 Hormetic synergy occurs within evolutionarily constrained limits.
12 Transient hormetic challenges can result in extended resilience.
13 An explanation of why the maximum stimulation of hormesis is over estimated.
14 An explanation of why the frequency of hormesis in the literature is underestimated